I didn’t expect two little sensors on my arms to change my relationship with food, anxiety, and my own sense of control. Personally, I think that’s the quiet trick of the current “metabolic optimisation” wave: it sells clarity, but it often delivers hypervigilance. And once you feel that shift happening—once social meals start to feel like lab reports—things get serious fast.
Continuous glucose monitoring (CGM) has moved from a tool mainly for diabetes into something marketed for non-diabetics, prediabetes, and even general “wellness” audiences. I tested CGMs as someone without diabetes, largely because the promise sounded reasonable: see how meals affect glucose, then make better choices. What I discovered over more than a year, though, is that the more “actionable” the data becomes, the more power it has to mess with your mind—especially when medicine still can’t agree on what the data should mean.
The marketing promise vs. the lived experience
The official pitch is straightforward. CGMs track glucose levels continuously by measuring glucose in the interstitial fluid just under the skin, giving you trends and patterns instead of one-off finger sticks. For people with Type 2 diabetes or prediabetes, that can be genuinely useful because insulin resistance often develops over time and lifestyle changes can matter early.
But here’s what makes this particularly fascinating (and uncomfortable) from my perspective: non-diabetics are being offered the same framing—“learn your body, prevent future disease”—without the same level of clinical consensus. What many people don’t realize is that a large chunk of CGM interpretation still sits in a grey zone, where the technology is clearer than the science and the messaging is faster than the medical guidelines. Personally, I think the wellness ecosystem likes certainty because uncertainty doesn’t sell subscriptions.
In my case, I wore two over-the-counter CGMs simultaneously for extended stretches—partly to compare how they behaved and partly because I wanted to know if “the truth” would look different depending on the brand. Unsurprisingly, I still didn’t get a neat answer; I got more questions. And the emotional cost of not knowing is what people rarely budget for.
“Control” can look a lot like anxiety
At first, CGM use felt almost invisible. I’d put the sensors on, check the apps to confirm readings were streaming, and move on with my day. Then the invisible part didn’t last. One day it snagged on clothing; another day I brushed a sensor against something and the small disruption felt disproportionate because the device had already planted the idea that my body was a dashboard.
After that, I started checking data constantly—morning, after workouts, hours after meals. Personally, I think this is the psychological trap: CGM turns your internal chemistry into a score you can look up at any time. Once you can observe something continuously, your brain treats it like something that must be managed continuously, even when the underlying issue isn’t urgent.
The anxiety didn’t just come from spikes—it came from the way apps teach you ranges. Both devices used “ideal” glucose targets in the healthy non-diabetic range (for example, commonly cited 70–140 mg/dL) and nudged me to interpret deviations as clues. In the early months, I was repeatedly seeing morning numbers that looked higher than expected, including alerts during sleep. In a normal world, that would trigger a simple question: “Is this real?” In my world, it triggered a more chaotic one: “What’s wrong with me?”
When medicine doesn’t agree, users become their own clinicians
One of the biggest lessons I learned is that disagreement isn’t just an academic issue—it becomes personal. Clinicians I spoke with generally told me my blood sugar wasn’t “diabetes territory,” especially because my A1C stayed in a healthy range. Yet I also had elevated liver enzymes and cholesterol, and that mix made the experience feel less like self-experimentation and more like detective work.
A deeper problem lurks underneath: CGMs aren’t perfect mirrors of blood glucose. CGMs estimate glucose in interstitial fluid, and accuracy has real limits even when devices meet regulatory standards. Personally, I think the public conversation often treats CGMs like magnifying glasses, when they’re more like imperfect translators. And when the translator isn’t trusted, every sentence feels suspect.
This matters even more because, as experts have pointed out, clinicians don’t share a single, agreed-upon framework for deciding what “slightly abnormal” CGM patterns in non-diabetics should lead to. In one study where endocrinologists reviewed CGM reports from non-diabetics, there was essentially no consensus on whether follow-up screening was warranted. From my perspective, that’s the clearest warning sign possible: even specialists can’t reliably convert CGM graphs into uniform medical next steps.
And then apps come along with tidy scores and simplified interpretations—sometimes with spike alerts, sometimes without. If you wear multiple CGMs (like I did), you can even get competing numbers and still have no grounded way to determine which one is “correct” for decision-making. It’s hard to feel calm when the instrument gives you data and the clinical system gives you ambiguity.
The “metabolism optimisation” culture is built for perfectionists
In my opinion, the most dangerous part of this trend isn’t biology—it’s behaviour. When you believe your metabolism is something you can constantly optimise, food stops being nourishment and becomes a performance review. I found myself turning ordinary meals into negotiations. A slice of pizza at a gathering could make me feel panicky. I started skipping snacks or avoiding social eating altogether because the thought of a spike alert felt like a moral failure.
Over time, I also overexercised. I’d feel “good” if fasting glucose looked low, and “bad” if it crossed a threshold—even when that threshold wasn’t clearly tied to an actionable diagnosis. What this really suggests, to me, is that CGM adoption doesn’t just change what you eat; it changes what you think you’re allowed to feel.
There’s research indicating that while it’s difficult to prove a direct causal link to eating disorders, wearables and diet-focused tracking can worsen symptoms for people who are vulnerable or already struggling. Personally, I didn’t think I was that person—until CGM data turned my world into a constant justification session. The terrifying part was how subtle it felt at first, and how quickly it turned social life into risk management.
The “win” story—and why I still hesitate to call it one
Eventually, the story did become medically meaningful. After a longer run, my CGM patterns looked worse, and I also pursued another set of blood tests with a new doctor. Still no diabetes or prediabetes diagnosis came out of it, but my cholesterol had worsened and liver enzymes had increased substantially. An ultrasound showed my fatty liver progressed from mild to moderate, and—this time—insulin resistance testing placed me high-side-of-normal.
Personally, I think this is where the conversation should get more honest. Non-diabetic CGM users sometimes want a clean narrative: “The device detected something early, then lifestyle fixed it.” That can happen, and I’m glad for the people who experience that clarity. But in my case, the turning point wasn’t just self-knowledge—it was treatment. Medication improved my numbers and my symptoms dramatically, and my morning glucose stopped looking persistently elevated.
So yes, CGM played a role. But if you take a step back and think about it, the bigger takeaway is more sobering: lifestyle alone didn’t “demystify” anything for me. It took months of uncertainty, several wrong emotional turns, and ultimately pharmacological support.
From my perspective, the problem with the silver-bullet narrative is that it hides the time cost and the psychological cost. People hear “control your health” and assume it means relief. Sometimes it means monitoring your body until you can’t stop watching it.
A broader trend: wearables are turning health into an always-on feed
This all connects to a wider cultural pattern. We’re living in a world where optimization has become a default setting—from workouts to sleep to productivity—and health data now fits that same logic. CGM is simply the newest, most emotionally charged ingredient in that recipe because glucose sits at the intersection of metabolism, chronic disease risk, and food identity.
One thing that immediately stands out is how policy and celebrity wellness can accelerate adoption before evidence and consensus are ready. When public figures suggest near-universal CGM wear in the future, I worry we’ll import today’s marketing certainty into tomorrow’s mass behaviour without the clinical scaffolding needed to support users who interpret ambiguous patterns as catastrophe. This raises a deeper question: do we want “data access,” or do we want “data that can actually guide decisions”?
In my opinion, the missing piece is interpretation infrastructure—clearer thresholds, better evidence on outcomes for non-diabetics, and communication that acknowledges uncertainty. Until then, the person holding the phone becomes the clinician by necessity, and that’s not a role most people can perform without collateral damage.
What I’d tell a friend considering CGM
If you’re non-diabetic and curious, I’m not here to shame curiosity. Personally, I think curiosity is healthy. I’m here to urge caution, especially around expectations and the emotional side of tracking.
- Treat CGM as a tool for learning, not as a verdict.
- Avoid living inside your app; consider limited testing windows rather than 24/7 vigilance.
- Don’t assume “healthy ranges” in an app equal “no problem,” especially when sleep position and measurement accuracy can shift readings.
- If tracking starts to interfere with meals, social life, or self-worth, that’s a real sign you need to step back.
After my experience, I now use CGMs only to test new features or specific hypotheses, not as an ongoing identity project. That compromise feels more humane.
Closing thought: “control” isn’t the same as “care”
My CGM journey took far longer—and felt far harsher—than I expected. It began as a rational experiment and ended as a lesson in how uncertainty, data visibility, and perfectionism can combine into something psychologically costly. If you’re lucky, CGM can help you catch metabolic issues sooner. If you’re not, it can turn everyday eating into an ongoing test you can’t pass.
Personally, I think the healthiest framing is this: CGM can be valuable, but it shouldn’t be marketed as control. Care requires context, clinical judgment, and sometimes medication—while optimisation alone can become a trap disguised as progress.
Would you like me to write this in a more punchy/short-form blog tone, or keep it closer to long-form magazine commentary?
